NCT01471847 2020-12-09A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to TrastuzumabNovartisPhase 1 Completed5 enrolled
NCT01572519 2020-11-20A Study of JNJ-40346527 in Patients With Relapsed or Refractory Hodgkin LymphomaJanssen Research & Development, LLCPhase 1 Completed21 enrolled